1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Unresectable Nasopharyngeal Carcinoma: new trials by email Literature Review of Unresectable Nasopharyngeal Carcinoma trials Research Report on Unresectable Nasopharyngeal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma Tislelizumab - Recurrent Nasopharyngeal Carcinoma, Unresectable Nasopharyngeal Carcinoma | Phase 2 | Unknown | Fudan University | 40 | 2019-04-15 | 2022-04-04 |
Carcinoma (1) · Head and Neck Neoplasms (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pharyngeal Diseases (1) · Pharyngeal Neoplasms (1) · Stomatognathic Diseases (1)
tislelizumab (1)
Fudan University (1)
China (1)
Xiaoshen Wang (1)